<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04018768</url>
  </required_header>
  <id_info>
    <org_study_id>17-01177</org_study_id>
    <nct_id>NCT04018768</nct_id>
  </id_info>
  <brief_title>Multimodal Analgesia With NSAID vs. Narcotics Alone After Shoulder Instability Surgery</brief_title>
  <official_title>Multimodal Analgesia With NSAID vs. Narcotics Alone After Shoulder Instability Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a single-center, prospective observational study. The study will compare post-
      operative pain scores and narcotic consumption between two groups of patients - one cohort
      will receive ibuprofen (Motrin) and Percocet (to be used as needed) while the other cohort
      will receive only Percocet. Both pain management options are considered to be standard of
      care.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Actual">February 1, 2019</completion_date>
  <primary_completion_date type="Actual">February 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Visual Analog Scale (VAS) Score</measure>
    <time_frame>30 Minutes, 1 Hour Post Surgery, 2 Hours Post Surgery, 3 Hours Post Surgery, 4 Hours Post Surgery</time_frame>
    <description>Scale consisting of a drawn line from 0 to 100 - the patient will be asked to mark where they believe their pain is (100 being worse pain).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Verbal Rating Scale (VRS)</measure>
    <time_frame>30 Minutes, 1 Hour Post Surgery, 2 Hours Post Surgery, 3 Hours Post Surgery, 4 Hours Post Surgery</time_frame>
    <description>Consisting of 4 points (0 = no pain, 1 = mild, 2 = moderate, and 3 = severe)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">80</enrollment>
  <condition>Shoulder Pain</condition>
  <arm_group>
    <arm_group_label>Ibuprofen + Percocet</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Percocet</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ibuprofen 600 mg</intervention_name>
    <description>MRN ending in an EVEN # will receive ibuprofen 600 mg to be taken every 8 hours (TID) as needed (PRN) and oxycodone/acetaminophen (Percocet) 5 mg/325 mg for pain that is not adequately controlled by the ibuprofen.</description>
    <arm_group_label>Ibuprofen + Percocet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oxycodone/acetaminophen (Percocet) 5 mg/325</intervention_name>
    <description>MRN ending in an ODD #: will receive the current standard of care postoperative pain management, which is Percocet 5 mg/325 mg every 6 hours PRN.</description>
    <arm_group_label>Ibuprofen + Percocet</arm_group_label>
    <arm_group_label>Percocet</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients indicated for isolated arthroscopic shoulder instability surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA class I-II

          -  Patients scheduled for arthroscopic shoulder instability surgery

        Exclusion Criteria:

          -  Contraindication to ibuprofen or oxycodone/acetaminophen (e.g. hypersensitivity,
             history of GI or bleeding disorder)

          -  Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia,
             etc.)

          -  Younger than 18 years of age or older than 65

          -  Any patient considered a vulnerable subject

          -  Patients on pain medication prior to surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kirk Campbell</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York Langone Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 29, 2019</study_first_submitted>
  <study_first_submitted_qc>July 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2019</study_first_posted>
  <last_update_submitted>May 28, 2020</last_update_submitted>
  <last_update_submitted_qc>May 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shoulder Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Acetaminophen, hydrocodone drug combination</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

